Presacral Tumors

Filed as a single comprehensive page, mirroring the source chapter's own organization: the presacral (retrorectal) space hosts a genuinely heterogeneous set of congenital, neurogenic, osseous, and miscellaneous tumor types, but they share one anatomic space, one evaluation pathway (MRI-centric imaging, selective biopsy), and one surgical decision framework (function-sparing for benign lesions, en bloc resection for malignant ones) — the same one-page-per-unifying-framework pattern already used for Anorectal Sexually Transmitted Infections, Pruritus Ani, and Anal Cancer.

Distinct from the "chronic presacral sinus tract" entity already covered on Colorectal Anastomotic Complications — that is a leak-specific complication of low colorectal/ coloanal anastomosis, not a primary tumor of the presacral space; both occupy the same anatomic region but are otherwise unrelated.

Epidemiology and anatomic considerations

The presacral (retrorectal) space is rare territory for disease — incidence as low as 1 in 40,000–60,000 hospital admissions in referral-center reports. Detection is increasingly incidental, via expanded use of cross-sectional imaging, since most patients are asymptomatic until tumors reach considerable size. See Colorectal Anatomy & Embryology for the foundational presacral-fascia/ presacral-space anatomy this chapter's content builds on. The space is bordered anteriorly by the mesorectum, posteriorly by the anterior table of the sacrum, inferiorly by the levator muscles, and laterally by the lumbosacral plexus, ureters, and iliac vessels.

Sacral nerve root function has direct bearing on operative planning: bilateral S2–S5 removal causes complete loss of bladder and bowel function; bilateral S3–S5 removal leaves 40% with normal bowel function and 25% with normal bladder function; bilateral S4–S5 removal leaves 100% with normal bowel function and 69% with normal bladder function; unilateral S1–S5 removal leaves 87% with normal bowel function and 89% with normal bladder function. S1 nerve root or sciatic nerve resection can cause foot drop. High sacrectomy (more than half the S1 vertebral body) can compromise pelvic stability, sometimes requiring sacropelvic reconstruction with metallic fixation, bone grafting, or 3D-printed titanium prostheses — especially when preoperative radiotherapy has increased fracture risk.

Clinical presentation and physical examination

Pain, when present, is typically vague, of long duration, and located in the pelvis, perineum, and/ or low back — heightened by sitting, improved by standing or walking. Because the pain is often mistaken for a psychiatric complaint (patients are sometimes referred to psychiatry when no cause is found on routine exam), diagnosis is frequently delayed. Pain is more often associated with malignant lesions and can be an ominous sign. Constipation, urinary/fecal incontinence, and sexual dysfunction suggest sacral nerve involvement from advanced tumors; leg and gluteal symptoms suggest extension and mass effect. Some patients present with longstanding perineal/sacrococcygeal discharge and are misdiagnosed and treated for pilonidal disease (see Pilonidal Disease — no ASCRS-chapter overlap in content, but a real differential-diagnosis pitfall the chapter explicitly calls out), perirectal abscess, fistula-in-ano (see Anal Fistula), or other conditions before the correct diagnosis is made — a cited series of seven presacral-cyst patients averaged 4.1 prior operative procedures before correct diagnosis and definitive resection.

Physical exam: digital rectal exam reveals an extra-rectal mass displacing the rectum anteriorly in all but a small percentage of patients; also assesses fixation/relation to surrounding structures (prostate, vagina, coccyx/sacrum) and evaluates for a post-anal dimple. Rigid or flexible proctosigmoidoscopy evaluates the mucosa and tumor extent — the most common endoscopic finding is normal mucosa with extrarectal mass effect; abnormal/inflamed mucosa suggests infection or erosion into the rectal wall. Neurologic evaluation of musculoskeletal reflexes and sacral nerve function should be performed if clinically indicated.

Imaging studies

CT and MRI have dramatically changed presacral tumor evaluation — both can distinguish cystic, solid, or mixed tumors and assess involvement of other pelvic structures. MRI is the gold-standard imaging modality given its high soft-tissue resolution, superior sensitivity for cord abnormalities (sacral nerve root involvement, foraminal encroachment, dural sac compression), and superior definition of bony involvement, pelvic sidewall invasion, and vascular anatomy — including identifying meningoceles without the risks of myelogram. Preoperative diagnostic accuracy of MRI has been reported as high as 100%, with 50–88% sensitivity and 92–97% specificity for differentiating benign from malignant disease. Low T1/high T2 signal, gadolinium enhancement, irregular/infiltrative margins, and heterogeneous or solid components are more often associated with malignancy. An anterior meningocele on sacral views can show the characteristic "scimitar sign" (sickle-shaped sacrum/hemisacral agenesis).

An algorithmic MR-imaging approach (Hosseini-Nik et al.) subdivides fat-containing masses into solid, cystic, or complex lesions (solid further split into well- or ill-defined; cystic split into unilocular or multilocular), differentiated in part by the presence/absence of sacral destruction.

Preoperative biopsy

An ongoing topic of debate — the need for biopsy is predicated on whether the result will change preoperative or operative management (e.g., surgical approach and margins differ significantly for neurofibroma vs. neurofibrosarcoma). When needed, transperineal or parasacral approaches are used depending on the anticipated resection field; the needle tract should be resected en bloc with the specimen to decrease seeding/recurrence risk, and the external needle entry site can be spot-tattooed for future identification. Transperitoneal, transrectal, and transvaginal biopsy approaches should be avoided. If histopathology reveals malignancy, en bloc complete or partial excision of the rectum or vagina becomes necessary if the biopsy tract traversed either organ. Biopsy of cystic lesions risks secondary infection and post-resection recurrence. Inadvertent biopsy of a meningocele may lead to meningitis and death — should not be biopsied due to cerebrospinal-fluid contamination risk. A cited series (Messick et al., 87 presacral tumors) found only 28% underwent preoperative biopsy, and of those, only 17% required excision of the biopsy site itself (all negative for malignancy) — the remaining 20 were followed clinically/radiographically without excision, with no reported tumor recurrence in the tract site.

Classification

The presacral space is composed of connective tissue, nerves, fat, and blood vessels; totipotential cells differentiating into all three germ layers (endoderm, ectoderm, mesoderm) explain the wide range of tumor types that can arise there. The Mayo classification (updated from the original Uhlig and Johnson scheme) organizes presacral tumors into four categories — congenital, neurogenic, osseous, and miscellaneous — each subcategorized as benign or malignant:

• Congenital — benign: adrenal rest tumor, anterior sacral meningocele, developmental cysts (dermoid, epidermoid, enterogenous/rectal duplication, tailgut/cystic hamartoma). Malignant: chordoma, germ cell tumor, malignant developmental cysts, teratocarcinoma.
• Neurogenic — benign: ganglioneuroma, neurofibroma, schwannoma (neurilemoma). Malignant: ganglioneuroblastoma, malignant schwannoma, neuroblastoma, peripheral nerve sheath tumors (neurofibrosarcoma), primitive neuroectodermal tumor.
• Osseous — benign: aneurysmal bone cyst, giant cell tumor, osteoblastoma, osteoma, simple bone cyst. Malignant: chondrosarcoma, Ewing's sarcoma, giant cell tumor (malignant transformation), myeloma, osteogenic sarcoma, plasmacytoma, reticulum cell sarcoma, spindle cell sarcoma.
• Miscellaneous — benign: aggressive angiomyxoma, benign GIST (see Gastrointestinal Stromal Tumors (GIST) for the fuller GIST biology), benign hemangiopericytoma, desmoid/fibromatosis, ectopic kidney, endothelioma, fibroma, hamartoma, hemangioma, leiomyoma, lipoma, lipofibroma, myelolipoma, pecoma, solitary fibrous tumor, tuberculosis. Malignant: angiosarcoma, carcinomasarcoma, degenerated hamartoma, epithelioid sarcoma, fibrosarcoma, fibromyxoid sarcoma, histiosarcoma, hydatid cyst, leiomyosarcoma, liposarcoma, lymphoma, malignant desmoid, malignant hemagiopericytoma, malignant GIST, malignant solitary fibrous tumor, metastatic carcinoma, myeloliposarcoma, neuroendocrine tumors, rhabdomyosarcoma, small cell tumor, spindle cell tumor, squamous cell carcinoma, undifferentiated sarcoma.

In general, two-thirds of presacral tumors are congenital (of which two-thirds are developmental cysts, with neurogenic tumors the next most common mass type); around 45–50% are malignant or have malignant change within them.

Epidermoid and dermoid cysts

More common in females; well-circumscribed with a thin outer layer, resulting from ectodermal- closure defects; often communicate with the skin surface via a postanal dimple; histologically keratinized stratified squamous epithelium. Often misdiagnosed as perirectal abscesses; recurrently infected cysts have been associated with squamous cell carcinoma development. Dermoid cysts may contain skin appendages (sweat glands, hair follicles, sebaceous cysts); epidermoid cysts do not.

Tailgut cysts

Congenital lesions arising from remnants of normally regressing postanal primitive hindgut, more common in females. Lined with columnar epithelium, can morphologically resemble the adult/fetal intestinal tract. Do not communicate with the rectal lumen; often multiloculated or biloculated, well-defined and homogenous. Presence of glandular/transitional epithelium differentiates them from epidermoid and dermoid cysts. Malignant transformation has been reported in some series.

Enterogenous cysts (rectal duplication cysts)

More common in women, often communicate with the rectum, thought to derive from developing hindgut (endodermal origin) — can be lined with squamous, cuboidal, columnar, or transitional epithelium. Three anatomic criteria for classification as a rectal duplication cyst: attached to the alimentary tract; lined by mucous membrane similar to the GI tract; possesses a smooth muscular coat. Tend to be multi-lobular with one dominant and smaller satellite cysts. Generally benign, though malignant transformation has been described in case reports.

Teratomas

Sacrococcygeal teratomas may include all three germ layers (totipotential cells), can contain both solid and cystic components, and are more common in the pediatric age group and in females. Can contain tissue from almost any organ system (digestive, nervous, respiratory, skeletal). Histologically mature or immature, reflecting cellular differentiation — the more recognizable the elements (hair, bone, teeth), the more likely the tumor is benign, though all should be viewed as potentially malignant. Cystic components are typically benign; solid components are more often associated with malignant degeneration. Often associated with anomalies of the vertebra, urinary tract, and anorectum. Malignancy risk correlates strongly with age: in infants, only 7% of girls and 10% of boys have malignancy prior to 2 months of age, vs. up to 48% and 67% respectively after 2 months. Malignant degeneration can occur in adults, and incomplete/intralesional resection increases the likelihood. Because of the diverse germ layers, these lesions can transform into squamous cell carcinoma (ectodermal origin), rhabdomyosarcoma (mesenchymal origin), or anaplastic (indeterminate cell of origin) tumors.

Chordomas

Sacrococcygeal chordomas are the most common malignant tumor of the presacral space. More common in males, rarely encountered under age 30. Thought to arise from vestigial notochord tissue (embryologically extending from the base of the occiput to the caudal limit); can occur almost anywhere on the spinal cord but most commonly in the spheno-occipital region at the skull base and the sacrococcygeal region of the pelvis. Symptoms are often vague (low back, pelvic, buttock pain — aggravated by sitting, alleviated by standing), so diagnosis is often delayed and tumors can reach considerable size, causing constipation and fecal/urinary incontinence and sexual dysfunction. Centrally, chordomas often contain extracellular mucin and can be soft, firm, or gelatinous; can contain hemorrhage areas and invade/destroy bone and soft tissue, extending into adjacent regions. Local and distant recurrence rates have been documented as 43% and 22% respectively; 5- and 10-year survival rates are 67% and 40%. Resection with negative margins is the treatment of choice — see Outcomes below for the extensive chordoma-specific outcomes literature (margin status is the most consistently identified predictor of survival across multiple large series).

Meningoceles

Anterior sacral meningoceles arise from protrusions of the thecal sac through a sacral defect, contain cerebrospinal fluid, and can be seen in conjunction with presacral cysts and lipomas. The classic radiographic finding is the "scimitar sign" (see Imaging studies above). Symptoms include headaches related to postural changes and the Valsalva maneuver, low back/pelvic pain, constipation/defecatory dysfunction, dyspareunia, and urinary urgency/retention/incontinence. Can be associated with other congenital anomalies including urinary tract/anal malformations, uterine/ vaginal duplication, tethered spinal cord, and spina bifida. Should not be biopsied given the risk of bacterial contamination of cerebrospinal fluid and iatrogenic meningitis (see Preoperative biopsy above). Surgical treatment: obliterating the communication between the subarachnoid space and herniated sac, detethering the spinal cord, and resecting the congenital tumor.

Neurogenic tumors

Arise from the peripheral pelvic nerve plexus; make up ~10–15% of all presacral masses, typically affecting younger patients (median age 38). Although the vast majority (>90%) are benign, differentiating benign from malignant can be difficult without tissue biopsy. Schwannomas and ependymomas are the two most commonly encountered lesions. Presenting symptoms can include neuropathies and low back/pelvic pain. Both benign and malignant tumors have a high local recurrence rate; survival for malignant tumors is poor. Early detection and aggressive surgical intervention are necessary to improve outcomes; a nerve-sparing technique can safely achieve a function-preserving resection with overall symptom improvement, though sacral nerve root sacrifice may be required for extended resections of malignant tumors.

Osseous tumors

Osseous lesions growing into the presacral space make up less than 10% of presacral tumors, arising from bone, cartilage, fibrous tissue, or marrow. More common in males; half are malignant at diagnosis. Can reach considerable size and cause significant local destruction, with pronounced metastatic potential (pulmonary most common). Although benign, giant cell tumors of the sacrum can metastasize to the lung and transform to a fulminant malignant variant with very poor prognosis.

Miscellaneous lesions

Can include heterogeneous pathologies: carcinoids, gastrointestinal stromal tumors (see Gastrointestinal Stromal Tumors (GIST) — this chapter adds only that presacral/retrorectal GIST is one of the rarer sites, distinct from the anal GIST content on Anal Cancer), dermoids, angiomyxomas, metastatic deposits, ectopic kidneys, and hematomas.

Currarino syndrome

A rare autosomal dominant congenital malformation (described 1981) linked to mutations in the HLXB9 gene (43 heterozygous mutations reported to date), though sporadic cases occur. Triad: sacral malformation (agenesis or sickle shape), hindgut anomaly, and presacral tumor. Patients can present with variable phenotypes including spinal cord anomalies (tethered cord, thickened filum, syrinx), genitourinary malformations, anorectal and gynecological anomalies, and more than one presacral lesion can occur in the same patient. Dermoid cyst is the most commonly associated presacral mass, though teratomas have been identified in 25–40% of cases. Malignancy in Currarino syndrome is rare, described in only a small number of adult patients (age 19–45) with malignant teratoma. An abnormal-looking sacrum on imaging is often the diagnostic tip-off.

Management

Surgical resection has historically been the recommendation for presacral tumors. Operative indications include known malignancy, concern for future malignant transformation, alleviation of symptoms, and tumor increase in size (which may make future resection more risky). Small tumors can be managed by colorectal surgeons trained in these lesions; larger tumors, or those associated with neuromusculoskeletal structures, are best managed by a multidisciplinary team (colorectal, orthopedic oncology, spine, neurosurgery, urology, vascular, plastic surgery, medical oncology, radiation oncology, musculoskeletal radiology, anesthesiology). The guiding surgical principles: a function-sparing approach for benign lesions and an en bloc oncologic approach for malignant lesions. A published decision-making algorithm splits purely cystic lesions (rarely malignant — meningocele vs. developmental cyst, level-based posterior vs. anterior/combined approach, or observation if small/asymptomatic) from solid or heterogeneous cystic lesions (biopsy first, then benign — observe if small/asymptomatic, or resect based on neurogenic-tumor status and level — vs. malignant — resectability-driven pathway through neoadjuvant therapy and en bloc resection, or chemotherapy ± palliative resection if unresectable).

There is emerging literature supporting nonoperative surveillance (serial imaging) for small cystic lesions without symptoms or suspicious radiologic features — one series followed six cystic lesions with serial imaging for a median of 20 months (range 5–66), and at last follow-up four (67%) were stable in size. The chapter's own practice considers an observational approach for small (<5 cm), asymptomatic neurogenic tumors.

Neoadjuvant therapy

Many malignant presacral tumors — chondrosarcomas and chordomas among them — are poorly responsive to radiotherapy and chemotherapy. Neoadjuvant therapy can still decrease tumor size, increase resectability, and potentially decrease local recurrence, with less morbidity than postoperative administration (smaller irradiation field). Ewing's and osteogenic sarcomas are associated with metastasis and neoadjuvant chemotherapy is a cornerstone of therapy for them. The approach for presacral sarcomas is extrapolated from soft-tissue-sarcoma protocols generally (retroperitoneal and extremity sarcoma radiation/chemotherapy trial evidence). Hormonal therapy has shown benefit reducing the size of giant aggressive angiomyxomas; immunotherapy is showing promise for advanced chordomas. It is unclear whether patients with malignant cysts benefit from neoadjuvant chemoradiotherapy given small case series and heterogeneous populations — the chapter's own practice uses this approach in malignant cysts containing squamous cell carcinoma or adenocarcinoma, reasoning by analogy to chemoradiotherapy's efficacy in rectal adenocarcinomas and anal squamous cancers (see Rectal Cancer and Anal Cancer).

Preoperative considerations

Optimize anemia, protein-calorie malnutrition, and debility before surgery; social work consultation for debilitated patients. Preoperative selective coil embolization of feeding vessels can decrease intraoperative bleeding in large vascular tumors like hemangiopericytomas. Multidisciplinary film review and operative planning, blood bank alert given potential for significant bleeding, and an experienced operating room team are all recommended for complex tumors.

Surgical approach

Location, involvement of other pelvic structures, and surgeon experience dictate approach. Tumors superior to the S3–4 sacral bodies: purely abdominal (anterior) approach. Tumors entirely inferior to S3–4: posterior sacral incision. Tumors extending both proximal and distal to S3–4: combined anterior and posterior approach.

Posterior approach

Prone jackknife position. Dissection carried to the distal sacrum/coccyx and through the anococcygeal ligament, avoiding damage to the sphincter complex. Coccygectomy can facilitate exposure and resection of larger or coccyx-tethered tumors. There has been ongoing debate about the utility of coccygectomy for every low presacral tumor — some authors advocate it improves exposure and decreases recurrence risk (the coccyx may harbor a nidus of totipotential cellular remnants), but multiple studies demonstrating low recurrence rates without coccygectomy support the idea that routine coccygectomy is unnecessary and potentially adds morbidity: Singer et al. did not perform coccygectomy in six of seven patients (86%) with benign lesions and saw no difference in recurrence; Mathis et al. performed coccygectomy in 7/28 patients (all resections of presacral tailgut cysts) and reported only a single recurrence (4%); Messick et al. performed coccygectomy in 51% of patients (44/87) and did not appreciate a difference in recurrence for those who did (14%) vs. did not (20%) undergo coccyx resection. The chapter's own practice favors coccygectomy specifically for sacrococcygeal teratomas, given uniform coccyx adherence and the highest recurrence risk if cyst components are left behind.

Abdominal and combined anterior/posterior approach

For tumors completely above S3–4, transabdominal approach; if the upper pole extends above S3, a combined approach is usually indicated. Bilateral ureteral stents can be placed for larger tumors. The sigmoid colon is mobilized and the presacral space entered; ureters and superior hypogastric nerves are identified and preserved; the mesorectum is dissected off the presacral fascia. If the tumor invades S2 or S3 nerve roots, en bloc excision of the rectum with the mass and creation of a permanent colostomy is appropriate. During mobilization of malignant tumors, no structures attached to the specimen (ureter, bone, vasculature, nerve) should be separated — they should be removed en bloc with the tumor. Selective ligation of the middle sacral artery and, in some cases, the internal iliac vessels and branches, can reduce blood loss during resection of large tumors requiring en bloc sacrectomy; preserving the anterior division of the internal iliac artery and internal gluteal branches reduces perineal/gluteal necrosis risk. For expected large pelvic or postsacral defects, a plastic surgeon should be involved for tissue interposition/reconstruction — options include VRAM (vertical rectus abdominis myocutaneous) flap (the same flap used for salvage-APR perineal reconstruction on Anal Cancer), TRAM flap, omental pedicle flap, gracilis flaps, and gluteus myocutaneous flap.

For extended sacral involvement, patients may be repositioned prone for a second, posterior-approach stage after the anterior dissection/colostomy is completed. A protective barrier (silastic mesh or similar) can be placed anterior to the sacrum during posterior osteotomy to reduce injury to vital structures and protect a pedicled flap already placed for later extraction. Posterior technique then proceeds through gluteus maximus dissection, transection of the sacrotuberous/sacrospinous ligaments, piriformis division to expose the sciatic nerve, osteotomy at the desired level (with preservation of uninvolved sacral nerve roots), and thecal sac closure with absorbable suture for resections at S2–S3 or higher (to prevent CSF leak/intradural infection). The tumor is removed en bloc with the sacrum, coccyx, and involved sacral nerve roots, with or without the rectum. If both S3 nerve roots are sacrificed, a permanent colostomy is often necessary.

Minimally invasive approaches

Laparoscopic and robotic techniques are increasingly described as safe/feasible for removing presacral tumors in selected patients — not generally feasible for very large tumors, or malignant tumors involving the pelvic sidewall, sacrum, or multiple viscera. A systematic review (Mullaney et al., Mayo Clinic) of 82 patients meeting inclusion criteria found: majority female (79.2%), mean age 41.7 years; 89% laparoscopic or combined laparoscopic-perineal resection, 10.8% robotic; conversion rate 5.5%; overall 30-day morbidity 15.7% (one intraoperative rectal injury); 95% of tumors benign; median length of stay 4 days for both laparoscopic and robotic groups; no tumor recurrence noted at median 28-month follow-up. Compared to historical open-surgery controls (systematic review of 1064 patients), minimally invasive approaches had similar mean operating time, shorter hospital stay (4 vs. 9 days), and comparable 30-day postoperative complications (16% vs. 12.2%) — selection bias is acknowledged as inherent to the comparison.

Outcomes

Difficult to draw firm conclusions given the heterogeneity and rarity of presacral tumors — most reported series come from tertiary/quaternary referral centers accumulated over years to decades, with great variability in follow-up regimens and an absence of time-to-event (Kaplan-Meier) calculation in many series. Across benign and malignant series (8- to 48-year spans, per the chapter's summary tables): recurrence rates for benign masses range 0–35% (highest for neurogenic tumors); recurrence rates for malignant lesions range 0–48%; a R0 resection with wide surgical margins is uniformly associated with lower rates of local recurrence across series.

The largest body of outcomes literature concerns chordomas specifically: McMaster et al. (National Cancer Institute, SEER database, 1973–1995, 400 cases) found 33% spinal, 32% cranial, 29% sacral, 6% extra-axial location. Fuchs et al. (Mayo Clinic, 52 sacrococcygeal chordoma patients, 1980–2001) found wide margin was the most important predictor of survival — all patients with a wide margin survived, significantly different from marginal/intralesional excision; lung metastasis developed in 31%, nearly all of whom also had local recurrence. Pan et al. (Xiangya Hospital, China, SEER database, 808 spinal chordoma patients 1973–2014) found 8% overall distant-metastasis rate, with age ≥60, distant metastasis, and non-surgical therapy independently associated with reduced survival (tumor site — vertebral vs. sacrum/pelvis — was not associated with survival). Kerekes et al. (Johns Hopkins, Duke, and the Netherlands; systematic review/pooled cohort analysis, 1980–2016, 57 studies, 1235 sacral chordoma cases) found wide surgical margin associated with lower local-recurrence rate; wide surgical margin, female sex, and age ≥65 years associated with lower distant-recurrence rate.

Follow-up and observation-only patients

Limited data exist to base firm follow-up recommendations on. The chapter's own practice: annual visit with DRE for patients who had benign lesions resected, pelvic MRI at 1 year post-resection and again at 5 years (with interim imaging if a mass is palpated). For malignant tumors: annual physical exam, pelvic MRI, and CT chest/abdomen for 5 years, with medical/radiation oncology collaboration for adjuvant-therapy needs; recurrences are considered for re-resection if complete resection is possible. For cystic lesions managed nonoperatively: pelvic MRI every 5 years for 10 years to assess natural history — longer imaging intervals if little change in size/morphology is noted, case-by-case decision-making, and patient counseling to prompt evaluation if symptoms change. A similar follow-up approach is recommended for benign solid tumors such as schwannomas.

Related pages

• Colorectal Anatomy & Embryology — the foundational presacral-fascia/presacral-space anatomy this chapter's content builds directly on.
• Colorectal Anastomotic Complications — that page's "chronic presacral sinus tract" content is a distinct, leak-specific entity occupying the same anatomic space; not to be confused with the primary tumors covered here.
• Gastrointestinal Stromal Tumors (GIST) — fuller GIST biology; presacral/retrorectal GIST is one of several rare sites, distinct from the anal-GIST content on Anal Cancer.
• Anal Cancer — shares the VRAM-flap reconstruction technique for large pelvic/perineal defects, and the chapter's reasoning-by-analogy for chemoradiotherapy in malignant presacral cysts containing squamous cell carcinoma.
• Rectal Cancer — shares the chemoradiotherapy reasoning-by-analogy noted above for malignant cysts containing adenocarcinoma.
• Pilonidal Disease, Anal Fistula — named by the chapter as common misdiagnoses that delay correct diagnosis of a presacral cyst (no direct content overlap, but a real clinical pitfall).

Open items / gaps

• Textbook chapter, not primary literature; the extensive chordoma-outcomes data (McMaster, Fuchs, Pan, Kerekes) and other cited series are the chapter authors' synthesis, not independently re-verified against the primary publications.
• The Mayo classification table (Table 21.1) is reproduced here in condensed prose form rather than as a full table; refer back to the source chapter for the complete entity list if a specific rare tumor type needs to be checked against the classification.
• This is the twenty-first chapter and the second chapter of Part III ("Malignant Disease"); no forward references were pending for this chapter specifically, though it draws on and cross-links several already-ingested pages as noted above.